| 405 |
Organo-Phosphate Chemicals induced inhibition of AChE leading to impaired cognitive function |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
402: Cognitive function, decreased
|
|
|
| 404 |
Metabolic Syndrome leading to Toll Like Receptor dysregulation |
Gillina Bezemer |
BY-SA |
None
|
None
|
|
|
| 403 |
combined unhealthy lifestyle factors leading to metabolic syndrome |
Gillina Bezemer |
BY-SA |
None
|
None
|
|
|
| 402 |
Thyroid peroxidase (TPO) inhibition leads to periventricular heterotopia formation in the developing rat brain |
Katherine (Katie) O'Shaughnessy |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
|
|
| 401 |
G protein-coupled estrogen receptor 1 (GPER) signal pathway in the lipid metabolism disrupting effects |
Fei Li |
BY-SA |
2029: protein-coupled estrogen receptor 1 (GPER) activation
|
1489: Increase, Steatohepatitis
|
|
|
| 400 |
Inhibition of CYP26B1 activity in fetal testis leading to reduced fertility |
Terje Svingen |
BY-SA |
1887: Inhibition of CYP26B1 activity
|
406: decreased, Fertility
|
|
|
| 399 |
Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos) |
Vid Modic |
BY-SA |
1884: Inhibition of Fyna
|
2 AOs
|
|
|
| 398 |
Decreased ALDH1A (RALDH) activity leading to decreased fertility via disrupted meiotic initiation of fetal oogonia |
Terje Svingen |
BY-SA |
1880: Decreased, ALDH1A (RALDH) enzyme activity
|
406: decreased, Fertility
|
Under Development |
1.97 |
| 397 |
Bulky DNA adducts leading to mutations |
Carole Yauk |
BY-SA |
1879: Bulky DNA adducts, increase
|
185: Increase, Mutations
|
Under Development |
1.11 |
| 396 |
Deposition of ionizing energy leads to population decline via impaired meiosis |
Erica Maremonti |
BY-SA |
1550: Deposition of Ionizing Energy
|
3 AOs
|
|
|
| 395 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on pericytes leads to disseminated intravascular coagulation resulting in cerebrovascular disease (stroke) |
Magda Sachana |
BY-SA |
1739: Binding to ACE2
|
1875: Cerebrovascular disease (stroke)
|
Under Development |
1.96 |
| 394 |
SARS-CoV-2 infection of olfactory epithelium leading to impaired olfactory function (short-term anosmia) |
Sandra Coecke |
BY-SA |
1739: Binding to ACE2
|
1873: impaired olfactory function (anosmia)
|
Under Development |
1.96 |
| 393 |
AOP for thyroid disorder caused by triphenyl phosphate via TRβ activation |
Fei Li |
BY-SA |
1158: Increased, Hepatic thyroid hormone uptake/transport
|
None
|
|
|
| 392 |
Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation |
Penny Nymark |
BY-SA |
2 MIEs
|
1868: Hyperinflammation
|
Under Development |
1.96 |
| 389 |
Oxygen-evolving complex damage leading to population decline via inhibition of photosynthesis |
Knut Erik Tollefsen |
BY-SA |
1865: Increase, Oxygen-evolving complex damage
|
2 AOs
|
|
|
| 388 |
Deposition of ionising energy leading to population decline via programmed cell death |
Knut Erik Tollefsen |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 387 |
Deposition of ionising energy leading to population decline via mitochondrial dysfunction |
Knut Erik Tollefsen |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 386 |
Deposition of ionizing energy leading to population decline via inhibition of photosynthesis |
Knut Erik Tollefsen |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 385 |
Viral spike protein interaction with ACE2 leads to microvascular dysfunction, via ACE2 dysregulation |
Julija Filipovska |
BY-SA |
1739: Binding to ACE2
|
None
|
|
|
| 384 |
Hyperactivation of ACE/Ang-II/AT1R axis leading to chronic kidney disease |
Young Jun Kim |
BY-SA |
1853: Hyperactivation of ACE/Ang-II/AT1R axis
|
1603: Chronic kidney disease
|
|
|
| 383 |
Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis |
Young Jun Kim |
BY-SA |
1740: Induced dysregulation of ACE2
|
344: Increase, Liver fibrosis
|
Under Development |
1.96 |
| 382 |
Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis |
Young Jun Kim |
BY-SA |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)
|
1276: Lung fibrosis
|
Under Development |
1.96 |
| 381 |
Binding of viral S-glycoprotein to ACE2 receptor leading to dysgeusia |
Young Jun Kim |
BY-SA |
1739: Binding to ACE2
|
1850: dysgeusia
|
Under Development |
1.96 |
| 379 |
Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation |
Shihori Tanabe |
All rights reserved |
1739: Binding to ACE2
|
1846: Thrombosis and Disseminated Intravascular Coagulation
|
Under Development |
1.96 |
| 378 |
Dysregulated underperforming Toll Like Receptors (TLRs) leading to high pathogen load |
Gillina Bezemer |
BY-SA |
1848: Toll Like Receptor (TLR) Dysregulation
|
None
|
|
|